Identification of CD39 as a Marker for the Circulating Malignant T-Cell Clone of Sézary Syndrome Patients

Armand Bensussan; Baptiste Janela; Nicolas Thonnart; Martine Bagot; Philippe Musette; Florent Ginhoux; Anne Marie-Cardine

doi:10.1016/j.jid.2018.09.026

Identification of CD39 as a Marker for the Circulating Malignant T-Cell Clone of Sézary Syndrome Patients

Armand Bensussan, Baptiste Janela, Nicolas Thonnart, Martine Bagot, Philippe Musette, Florent Ginhoux, Anne Marie-Cardine

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

6 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	725-728
Nombre de pages	4
journal	Journal of Investigative Dermatology
Volume	139
Numéro de publication	3
Les DOIs	https://doi.org/10.1016/j.jid.2018.09.026
état	Publié - 1 mars 2019
Modification externe	Oui

Accès au document

10.1016/j.jid.2018.09.026

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{569736d7db5240dda59d219ae3c6749b,

title = "Identification of CD39 as a Marker for the Circulating Malignant T-Cell Clone of S{\'e}zary Syndrome Patients",

author = "Armand Bensussan and Baptiste Janela and Nicolas Thonnart and Martine Bagot and Philippe Musette and Florent Ginhoux and Anne Marie-Cardine",

note = "Funding Information: This work was supported by grants from INSERM and Paris Diderot University. We thank H. Sicard (Innate Pharma, Marseille, France) for the kind gift of the anti-KIR3DL2 antibody. ",

year = "2019",

month = mar,

day = "1",

doi = "10.1016/j.jid.2018.09.026",

language = "English",

volume = "139",

pages = "725--728",

journal = "Journal of Investigative Dermatology",

issn = "0022-202X",

number = "3",

}

TY - JOUR

T1 - Identification of CD39 as a Marker for the Circulating Malignant T-Cell Clone of Sézary Syndrome Patients

AU - Bensussan, Armand

AU - Janela, Baptiste

AU - Thonnart, Nicolas

AU - Bagot, Martine

AU - Musette, Philippe

AU - Ginhoux, Florent

AU - Marie-Cardine, Anne

N1 - Funding Information: This work was supported by grants from INSERM and Paris Diderot University. We thank H. Sicard (Innate Pharma, Marseille, France) for the kind gift of the anti-KIR3DL2 antibody.

PY - 2019/3/1

Y1 - 2019/3/1

UR - http://www.scopus.com/inward/record.url?scp=85059190901&partnerID=8YFLogxK

U2 - 10.1016/j.jid.2018.09.026

DO - 10.1016/j.jid.2018.09.026

M3 - Article

C2 - 30798854

AN - SCOPUS:85059190901

SN - 0022-202X

VL - 139

SP - 725

EP - 728

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

IS - 3

ER -